Form 4: Certara Inc. Executive Adrian McKemey Reports Acquisition of Performance Stock Units and Restricted Stock Units

Adrian McKemey, President of Drug Development Solutions at Certara, Inc., reports the acquisition of performance stock units and restricted stock units.

Summary

• Adrian McKemey, President of Drug Development Solutions at Certara, Inc., filed a Form 4 detailing changes in beneficial ownership.
• On May 20, 2025, McKemey acquired 48,820 performance stock units (PSUs) and 32,547 restricted stock units (RSUs).
• The PSUs were granted under the 2025 Long-Term Incentive Plan and will vest based on the company's total shareholder return through March 31, 2028, with potential payout ranging from 0% to 200% of the target amount.
• The RSUs were granted under the 2020 Incentive Plan and will vest in three equal installments on April 1, 2026, April 1, 2027, and April 1, 2028.
• Each PSU and RSU represents a conditional right to receive one share of Certara, Inc. common stock or the cash equivalent for RSUs.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, indicating stability and alignment of interests. The sentiment is neutral to positive as it suggests confidence in the company's future performance.

Positives

• The grant of PSUs and RSUs aligns executive compensation with company performance and shareholder value.
• The vesting schedules for both PSUs and RSUs encourage long-term commitment from the executive.

Risks

• The value of the PSUs is contingent on Certara's total shareholder return, which is subject to market fluctuations and company performance.
• The RSUs are subject to continued employment through the vesting dates.

Future Outlook

The performance stock units will vest based on the company's performance against certain total shareholder return thresholds through the period ending on March 31, 2028.

Industry Context

Grants of performance-based equity compensation are common in the pharmaceutical and healthcare technology industries to incentivize executives and align their interests with those of shareholders.

Comparison to Industry Standards

• Companies like ICON plc and Medidata Solutions (now part of Dassault Systèmes) also utilize performance-based equity compensation for their executives.
• The specific terms of the PSU and RSU grants, such as vesting schedules and performance metrics, are generally aligned with industry practices for companies of similar size and stage.

Stakeholder Impact

• Shareholders may view the equity grants positively as they align executive interests with shareholder value creation.
• Employees may see the grants as a sign of the company's commitment to its leadership team.

Key Dates

Keywords

Form 4, Certara, McKemey, Performance Stock Units, Restricted Stock Units, Beneficial Ownership, Incentive Plan, Executive Compensation